Primary Job Title Partner Emeritus Primary Organization New Enterprise Associates
Location Washington, District of Columbia, United States Regions Washington DC Metro Area, Southern US Gender Male Also Known As james barrett, Jim Barrett
Investor Type
LinkedIn View on LinkedIn
James Barrett is a General Partner at New Enterprise Associates (NEA). He specializes in biotechnology and works with members of NEA's healthcare investment group on medical devices, healthcare information systems, and healthcare services companies.
He is a director of Cardioxyl Pharmaceuticals, GlycoMimetics, Inhibitex, Nucleonics,
Peptimmune, Predictive Biosciences, Proteostasis Therapeutics, Ruxton Pharmaceuticals, Sensors for Medicine and Science, Supernus Pharmaceuticals, Targacept, and Zosano Pharma.
Prior to joining NEA, James Barrett served as Founder, Chairman, and CEO of Sensors for Medicine and Science, where he remains Chairman.
Prior to that, he led three NEA-funded companies, serving as Chairman and CEO of Genetic Therapy, President and CEO of Life Technologies, and President and CEO of Bethesda Research Labs.
Previously, he worked in various divisions of GlaxoSmithKline.
James Barrett received a Ph.D. in Biochemistry at the University of Tennessee, an M.B.A. from the University of Santa Clara, and a B.S. in Chemistry from Boston College.
